The “third goal” of the Academy – the transfer of academic knowledge to industry and society.
Although there are successful and well-known cases such as those of Mobilai, whose activities evolved from image processing technology developed by Prof. Amnon Sheshua, one of the company’s founders, in his academic research. Another example is Copaxone, a multiple sclerosis drug developed at the Weizmann Institute, which is responsible for a significant portion of Teva’s revenue. Nevertheless, a report from the Samuel Neaman Institute published in the Globes suggested a policy change that defines the goals of the commercial departments – from financial goals to knowledge dissemination to society and industry.
